This one ? I’ll have to look through it. It has

New Post Public Reply Private Reply Replies (2) Message Board
Riztheinvestor Number1Stocker #100075
639
This one ?
I’ll have to look through it. It has Pattersons Twitter stuff on it .


“Explanatory Note

The participants named herein (collectively, “the Participants”), have filed a preliminary proxy statement and accompanying WHITE proxy card (the “Preliminary Proxy Statement”) with the Securities and Exchange Commission (the “SEC”) to be used to solicit votes for the election of its slate of director nominees at the 2021 annual meeting of stockholders of CytoDyn Inc., a Delaware corporation (the “Company”).

Subsequent to the Participants filing the Preliminary Proxy Statement with the SEC, the Company filed a complaint in the United States District Court for the District of Delaware: CytoDyn Inc. v. Rosenbaum et al., 1:21-cv-01139-UNA (D. Del.), filed August 6, 2021. The complaint alleges that, among other things, Bruce Patterson, M.D. (“Dr. Patterson”) and Jeffrey Paul Beaty (“Mr. Beaty”) violated provisions of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules promulgated thereunder by making public statements on social media that constitute solicitations prior to the publication of the Preliminary Proxy Statement, that such statements did not include any required disclaimer language and were not filed with the SEC on the first day of use, and that such statements were false and misleading. The complaint seeks, among other things, a declaration that Dr. Patterson and Mr. Beaty’s social media statements violated the Exchange Act and the rules promulgated thereunder, an order that the Participants publicly correct their material misstatements or omissions relating to Company securities, including by filing with the SEC complete and accurate disclosures required by the Exchange Act, and to preliminarily and permanently enjoin the Participants from publishing any soliciting materials, or soliciting any proxies or voting any proxies given to them, until they file such complete and accurate disclosures and the market has had enough time to absorb the information.

The Participants believe that the entire complaint lacks merit. However, with respect to Dr. Patterson’s and Mr. Beaty’s social media statements, while the Participants believe that such social media statements do not constitute solicitations under the Exchange Act and the rules promulgated thereunder and otherwise comply fully with applicable law, in order to moot certain of the Company’s claims, avoid nuisance and possible expense and delay, and provide additional information to the Company’s stockholders, the Participants have determined to file certain of Dr. Patterson’s and Mr. Beaty’s social media statements below as soliciting material under Rule 14a-12 of the Exchange Act. Nothing in the below disclosure shall be deemed an admission of the legal merit, necessity or materiality under applicable law of any of the disclosure set forth herein or within the Preliminary Proxy Statement. To the contrary, the Participants deny the abovementioned allegations in the complaint that any filings with the SEC were required with respect to Dr. Patterson’s and Mr. Beaty’s social media statements or that such statements were false and misleading.”

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 4

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading

Top 5 Most Recently Viewed Articles

ketteQ Raises $20M to Propel AI-Driven Supply Chain Solutions

Updated Category News Views 173

ketteQ Secures Significant Funding for Global Advancement Funding round supports ketteQ's mission to deliver adaptive planning, AI-powered insights, and measurable results in months, not years. ketteQ, a leader in adaptive supply chain planning solutions, has successfully raised $20 million in Series B funding, spearheaded by Vocap Partners. This fresh funding is set to...

Continue Reading
Cathie Wood's ARK Funds Make Strategic Moves in Tech Investments

Updated Category News Views 340

Overview of ARK's Recent Trading Activity Cathie Wood's ARK ETFs are well-known for their assertive trading strategies, and the most recent report reveals their latest stock moves. The firm has made headlines again by announcing a series of buy and sell transactions that display its ongoing commitment to innovation and growth in the tech sector. Let's dive into the...

Continue Reading
NEWTON GOLF Unveils $1 Million Share Repurchase Initiative

Updated Category News Views 119

NEWTON GOLF Announces Share Repurchase Authorization CAMARILLO, CA -- NEWTON GOLF Company (Nasdaq: SPGC), a leading innovator in the golf industry, has announced an authorization for a share repurchase program amounting to $1 million. This decision reflects a robust strategy to leverage market conditions and enhance shareholder value. The repurchase program will commence...

Continue Reading
Veritone Class Action: Stakes High for Shareholders

Updated Category News Views 3

Veritone's Legal Turbulence: Class Action Looms Alright, folks, here we go—a class action's got Veritone, Inc. (NASDAQ: VERI) in hot water, and it's not looking pretty. Legal eagles over at Robbins LLP are spearheading this suit, claiming the AI company botched its financial reporting. If you're holding VERI shares from October 14, 2025, through April 14, 2026, listen...

Continue Reading
TimelyCare Excellently Recognized for Mental Health Support

Updated Category News Views 180

TimelyCare Receives Prestigious Award for Mental Health Advocacy TimelyCare, known as higher education's most trusted virtual health and well-being provider, is honored to be recognized in the "Best in Business" list by Inc. for its exceptional advocacy in mental health. A Commitment to Student Health and Wellness As a winner in the Mental Health Advocacy category,...

Continue Reading